[1] World Health Organization (WHO) (2009) Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. WHO Press, Geneva.
[2] Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (2014) Cardiovascular Disease, Chronic Kidney Disease, and Diabetes Mortality Burden of Cardiometabolic Risk Factors from 1980 to 2010: A Comparative Risk Assessment. The Lancet Diabetes & Endocrinology, 2, 634-647.
http://dx.doi.org/10.1016/S2213-8587(14)70102-0
[3] Kearney, P.M., Whelton, M., Reynolds, K,, Muntner, P., Whelton, P.K. and He, J. (2005) Global Burden of Hypertension: Analysis of Worldwide Data. The Lancet, 365, 217-223. http://dx.doi.org/10.1016/S0140-6736(05)70151-3
[4] Brasil. Ministério da Saúde. Secretaria de Vigilancia em Saúde. (2014) Vigitel Brazil 2013: Protective and Risk Factors for Chronic Diseases by Telephone Survey. Ministério da Saúde, Secretaria de Vigilancia em Saúde. Ministério da Saúde, Brasília.
[5] Lee, I.M., Shiroma, E.J., Lobelo, F., Puska, P., Blair, S.N. and Katzmarzyk, P.T., Lancet Physical Activity Series Working Group (2012) Effect of Physical Inactivity on Major Non-Communicable Diseases Worldwide: An Analysis of Burden of Disease and Life Expectancy. The Lancet, 380, 219-229.
http://dx.doi.org/10.1016/S0140-6736(12)61031-9
[6] Pischon, T., Boeing, H., Hoffmann, K., Bergmann, M., Schulze, M.B., Overvad, K., et al. (2008) General and Abdominal Adiposity and Risk of Death in Europe. New England Journal of Medicine, 359, 2105-2120. http://dx.doi.org/10.1056/NEJMoa0801891
[7] Kelly, T., Yang, W., Chen, C.S., Reynolds, K. and He, J. (2008) Global Burden of Obesity in 2005 and Projections to 2030. International Journal of Obesity (Lond), 32, 1431-1437.
http://dx.doi.org/10.1038/ijo.2008.102
[8] Beevers, G., Lip, G.Y.H. and O’Brien, E. (2001) ABC of Hypertension: The Pathophysiology of Hypertension. BMJ, 322, 912-916. http://dx.doi.org/10.1136/bmj.322.7291.912
[9] Sanjuliani, A.F. (2002) Pathophysiology of Hypertension: Useful Theoretical Concepts for Clinical Practice. Revista SOCERJ, 15, 210-218.
[10] Carvalho, J.J., Baruzzi, R.G., Howard, P.F., Poulter, N., Alpers, M.P., Franco, L.J., et al. (1989) Blood Pressure in Four Remote Populations in the INTERSALT Study. Hypertension, 14, 238-246.
http://dx.doi.org/10.1161/01.HYP.14.3.238
[11] Schlaich, M.P., Klingbeil, A.U., Jacobi, J., Delles, C., Schneider, M.P., Schmidt, B.M., et al. (2002) Altered Aldosterone Response to Salt Intake and Angiotensin II Infusion in Young Normotensive Men with Parental History of Arterial Hypertension. Journal of Hypertension, 20, 117-124.
http://dx.doi.org/10.1097/00004872-200201000-00017
[12] Campos, L.A., Cipolla-Neto, J., Amaral, F.G., Michelini, L.C., Bader, M. and Baltatu, O.C. (2013) The Angiotensin-Melatonin Axis. International Journal of Hypertension, 2013, Article ID: 521783.
[13] Francischetti, E.A. and Genelhu, V.A. (2007) Obesity-Hypertension: An Ongoing Pandemic. International Journal of Clinical Practice, 61, 269-280. http://dx.doi.org/10.1111/j.1742-1241.2006.01262.x
[14] Nielsen, S., Guo, Z., Johnson, C.M., Hensrud, D.D. and Jensen, M.D. (2004) Splanchnic Lipolysis in Human Obesity. Journal of Clinical Investigation, 113, 1582-1588. http://dx.doi.org/10.1172/JCI21047
[15] Hall, J.E., da Silva, A.A., do Carmo, J.M., Dubinion, J., Hamza, S., Munusamy, S., et al. (2010) Obesity-Induced Hypertension: Role of Sympathetic Nervous System, Leptin, and Melanocortins. Journal of Biological Chemistry, 285, 17271-17276. http://dx.doi.org/10.1074/jbc.R110.113175
[16] Miall, W.E. and Oldham, P.D. (1963) The Hereditary Factor in Arterial Blood-Pressure. BMJ, 1, 75-80. http://dx.doi.org/10.1136/bmj.1.5323.75
[17] Ehret, G.B. and Caulfield, M.J. (2013) Genes for Blood Pressure: An Opportunity to Understand Hypertension. European Heart Journal, 34, 951-961. http://dx.doi.org/10.1093/eurheartj/ehs455
[18] Bauman, A.E., Reis, R.S., Sallis, J.F., Wells, J.C., Loos, R.J. and Martin, B.W., Lancet Physical Activity Series Working Group (2012) Correlates of Physical Activity: Why Are Some People Physically Active and Others Not? Lancet, 380, 258-271. http://dx.doi.org/10.1016/S0140-6736(12)60735-1
[19] Klingberg, F. and Klengel, S. (1993) Lesions in Four Parts of the Basal Forebrain Change Basic Behavior in Rats. NeuroReport, 4, 639-642. http://dx.doi.org/10.1097/00001756-199306000-00009
[20] Simonen, R.L., Perusse, L., Rankinen, T., Rice, T., Rao, D.C. and Bouchard, C. (2002) Familial Aggregation of Physical Activity Levels in the Quebec Family Study. Medicine & Science in Sports & Exercise, 34, 1137-1142. http://dx.doi.org/10.1097/00005768-200207000-00014
[21] Aaltonen, S., Ortega-Alonso, A., Kujala, U.M. and Kaprio, J. (2010) A Longitudinal Study on Genetic and Environmental Influences on Leisure Time Physical Activity in the Finnish Twin Cohort. Twin Research and Human Genetics, 13, 475-481. http://dx.doi.org/10.1375/twin.13.5.475
[22] Ekelund, U., Brage, S., Besson, H., Sharp, S. and Wareham, N.J. (2008) Time Spent Being Sedentary and Weight Gain in Healthy Adults: Reverse or Bidirectional Causality? American Journal of Clinical Nutrition, 88, 612-617.
[23] Metcalf, B.S., Hosking, J., Jeffery, A.N., Voss, L.D., Henley, W. and Wilkin, T.J. (2011) Fatness Leads to Inactivity, but Inactivity Does Not Lead to Fatness: A Longitudinal Study in Children. Archives of Disease in Childhood, 96, 942-947. http://dx.doi.org/10.1136/adc.2009.175927
[24] Allison, D.B., Faith, M.S. and Nathan, J.S. (1996) Risch’s Lambda Values for Human Obesity. International Journal of Obesity and Related Metabolic Disorders, 20, 990-999.
[25] Bouchard, C. (2008) Gene-Environment Interactions in the Etiology of Obesity: Defining the Fundamentals. Obesity, 16, S5-S10. http://dx.doi.org/10.1038/oby.2008.528
[26] Manolio, T.A. (2010) Genomewide Association Studies and Assessment of the Risk of Disease. New England Journal of Medicine, 363, 166-176. http://dx.doi.org/10.1056/NEJMra0905980
[27] Chorostowska-Wynimko, J. (2002) Mechanism of B2-Agonists Action and Safety Aspects. Polski Merkuriusz Lekarski, 12, 441-444.
[28] Snyder, E.M., Johnson, B.D. and Joyner, M.J. (2008) Genetics of β2-Adrenergic Receptors and the Cardiopulmonary Response to Exercise. Exercise and Sport Sciences Reviews, 2, 98-105.
http://dx.doi.org/10.1097/JES.0b013e318168f276
[29] Balligand, J.L. (2013) β3-Adrenoreceptors in Cardiovascular Diseases: New Roles for an “Old” Receptor. Current Drug Delivery, 10, 64-66. http://dx.doi.org/10.2174/1567201811310010011
[30] Zhang, H., Wu, J. and Yu, L. (2014) Association of Gln27Glu and Arg16Gly Polymorphisms in β2-Adrenergic Receptor Gene with Obesity Susceptibility: A Meta-Analysis. PLoS ONE, 9, e100489.
http://dx.doi.org/10.1371/journal.pone.0100489
[31] Snyder, E.M., Beck, K.C., Dietz, N.M., Eisenach, J.H., Joyner, M.J., Turner, S.T., et al. (2006) Arg16Gly Polymorphism of the β2-Adrenergic Receptor is Associated with Differences in Cardiovascular Function at Rest and during Exercise in Humans. The Journal of Physiology, 571, 121-30.
http://dx.doi.org/10.1113/jphysiol.2005.098558
[32] Sipil?inen, R., Uusitupa, M., Heikkinen, S., Rissanen, A. and Laakso, M. (1997) Polymorphism of the β3-Adrenergic Receptor Gene Affects Basal Metabolic Rate in Obese Finns. Diabetes, 46, 77-80.
http://dx.doi.org/10.2337/diabetes.46.1.77
[33] Villares, S.M., Mancini, M.C., Gomez, S., Charf, A.M., Frazzatto, E. and Halpern, A. (2000) Association between Polymorphism Gln27Glu of β2-Adrenergic Receptor and Hypertension in Morbid Obese. Arquivos Brasileiros de Endo crinologia e Metabologia, 44, 72-80.
[34] Rauhio, A., Uusi-Rasi, K., Nikkari, S.T., Kannus, P., Siev?nen, H. and Kunnas, T. (2013) Association of the FTO and ADRB2 Genes with Body Composition and Fat Distribution in Obese Women. Maturitas, 76, 165-171.